UN Opens Trieste Biotech Lab

TRIESTE—This week Arturo Falaschi takes charge of 900 square meters of laboratory and office space in a newly completed facility just outside Trieste in northern Italy. He does so as director of the Italian portion of the new International Center for Genetic Engineering and Biotechnology (ICGEB), set up by the United Nations Industrial Development Organization (UNIDO) to bring the benefits of recombinant DNA and associated technologies to Third World countries. The Trieste lab and its coun

Written byAngiola Bono
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Trieste lab and its counterpart in New Delhi, India, will each have 30 scientists, 20 postdoctoral researchers and 40 technicians. Many of the staff will be on two- to three-year appointments.

Both Falaschi and the ICGEB's General Director, I.C. (Irwin) Gunsalus, face uncertainty about future funding and the problem of attracting top-quality senior staff. Gunsalus, emeritus professor of biochemistry at the University of Illinois, was named this winter to head the new institute, following the abrupt departure two years ago of Burke Zimmerman, the original project leader who had hoped to become overall director.

Gunsalus, now working with UNIDO in Vienna, plans to join the Trieste center later this year. He recently appointed Krishna Tewari, chairman of the department of biochemistry and molecular Biology at the University of California, Irvine, as director of the ICGEB's New Delhi component. Six years after the ICGEB was first conceived, it has yet ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies